Atsushi Takano

3.2k total citations
63 papers, 2.5k citations indexed

About

Atsushi Takano is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Atsushi Takano has authored 63 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Molecular Biology, 22 papers in Oncology and 11 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Atsushi Takano's work include RNA modifications and cancer (11 papers), Lung Cancer Treatments and Mutations (8 papers) and 3D Printing in Biomedical Research (6 papers). Atsushi Takano is often cited by papers focused on RNA modifications and cancer (11 papers), Lung Cancer Treatments and Mutations (8 papers) and 3D Printing in Biomedical Research (6 papers). Atsushi Takano collaborates with scholars based in Japan, United States and Singapore. Atsushi Takano's co-authors include Yataro Daigo, Nobuhisa Ishikawa, Eiju Tsuchiya, Nobuoki Kohno, Kouki Inai, Hitoshi Nishimura, Wataru Yasui, Yohei Miyagi, Haruhiko Nakayama and Hiroyuki Ito and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.

In The Last Decade

Atsushi Takano

55 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Atsushi Takano Japan 25 1.5k 760 473 392 332 63 2.5k
Jamila Laoukili Netherlands 20 1.7k 1.2× 548 0.7× 316 0.7× 293 0.7× 315 0.9× 30 2.5k
Kenkichi Masutomi Japan 28 2.0k 1.3× 807 1.1× 210 0.4× 592 1.5× 447 1.3× 57 3.2k
Kiera Rycaj United States 22 1.4k 1.0× 770 1.0× 433 0.9× 288 0.7× 572 1.7× 29 2.2k
Yongwei Sun China 30 1.4k 0.9× 1.0k 1.3× 326 0.7× 405 1.0× 854 2.6× 107 2.7k
Christine Jean France 24 1.5k 1.0× 793 1.0× 186 0.4× 460 1.2× 446 1.3× 52 2.9k
Kou‐Juey Wu Taiwan 30 2.5k 1.7× 661 0.9× 413 0.9× 259 0.7× 894 2.7× 59 3.6k
Assunta De Rienzo United States 21 1.4k 1.0× 788 1.0× 772 1.6× 763 1.9× 389 1.2× 38 2.9k
Geoffrey Bartholomeusz United States 24 2.0k 1.4× 1.1k 1.4× 542 1.1× 231 0.6× 482 1.5× 45 3.1k
Wen Cheng China 28 1.1k 0.8× 406 0.5× 418 0.9× 449 1.1× 683 2.1× 99 2.1k
Juan Martín‐Caballero Spain 29 1.9k 1.3× 1.4k 1.8× 167 0.4× 441 1.1× 376 1.1× 43 3.0k

Countries citing papers authored by Atsushi Takano

Since Specialization
Citations

This map shows the geographic impact of Atsushi Takano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Atsushi Takano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Atsushi Takano more than expected).

Fields of papers citing papers by Atsushi Takano

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Atsushi Takano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Atsushi Takano. The network helps show where Atsushi Takano may publish in the future.

Co-authorship network of co-authors of Atsushi Takano

This figure shows the co-authorship network connecting the top 25 collaborators of Atsushi Takano. A scholar is included among the top collaborators of Atsushi Takano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Atsushi Takano. Atsushi Takano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Takano, Atsushi, et al.. (2024). Characterization of KIF20B as a novel prognostic biomarker and therapeutic target for breast cancer. International Journal of Oncology. 64(4). 1 indexed citations
3.
Takano, Atsushi, Yohei Miyagi, & Yataro Daigo. (2023). MO13-5 Identification of URST1 as a biomarker and therapeutic target for lung cancer. Annals of Oncology. 34. S1405–S1405.
4.
Sumimoto, Hidetoshi, Atsushi Takano, Koji Teramoto, & Yataro Daigo. (2019). Detection of neoantigen-reactive T cell clones based on the clonal expansion using next-generation sequencing of T cell receptor β complementarity-determining region 3. Journal of Immunological Methods. 476. 112679–112679. 2 indexed citations
5.
Sumimoto, Hidetoshi, et al.. (2016). RAS-MAPK signaling is required for the enhanced PD-L1 expression in human lung cancers. Annals of Oncology. 27. vii85–vii86. 1 indexed citations
6.
Nishino, Ryohei, Atsushi Takano, Masato Aragaki, et al.. (2013). RASEF is a Novel Diagnostic Biomarker and a Therapeutic Target for Lung Cancer. Molecular Cancer Research. 11(8). 937–951. 24 indexed citations
7.
Masuda, Ken, Atsushi Takano, Hirohiko Akiyama, et al.. (2011). Chondrolectin Is a Novel Diagnostic Biomarker and a Therapeutic Target for Lung Cancer. Clinical Cancer Research. 17(24). 7712–7722. 21 indexed citations
8.
Nishino, Ryohei, Atsushi Takano, Nobuhisa Ishikawa, et al.. (2011). Identification of Epstein-Barr Virus–Induced Gene 3 as a Novel Serum and Tissue Biomarker and a Therapeutic Target for Lung Cancer. Clinical Cancer Research. 17(19). 6272–6286. 65 indexed citations
9.
Takano, Atsushi, et al.. (2011). On-chip incubation system for long-term microfluidic cell culture. PubMed. 2011. 8404–8407. 3 indexed citations
10.
Sato, Nagato, Takumi Yamabuki, Atsushi Takano, et al.. (2010). Wnt Inhibitor Dickkopf-1 as a Target for Passive Cancer Immunotherapy. Cancer Research. 70(13). 5326–5336. 129 indexed citations
11.
Tanaka, Masaya, et al.. (2010). . Journal of The Japan Institute of Electronics Packaging. 13(5). 351–357. 3 indexed citations
12.
Takano, Atsushi, Nobuhisa Ishikawa, Ryohei Nishino, et al.. (2009). Identification of Nectin-4 Oncoprotein as a Diagnostic and Therapeutic Target for Lung Cancer. Cancer Research. 69(16). 6694–6703. 211 indexed citations
13.
Futai, Nobuyuki, et al.. (2009). On-chip Co2 incubation of microfluidic cell culture devices by humidity/gas exchange through poly (dimethylsiloxane) membrane. 47(6). 529–534.
14.
Kato, Tatsuya, Nagato Sato, Atsushi Takano, et al.. (2008). Activation of Placenta-Specific Transcription Factor Distal-less Homeobox 5 Predicts Clinical Outcome in Primary Lung Cancer Patients. Clinical Cancer Research. 14(8). 2363–2370. 45 indexed citations
15.
Ishikawa, Nobuhisa, Atsushi Takano, Wataru Yasui, et al.. (2007). Cancer-Testis Antigen Lymphocyte Antigen 6 Complex Locus K Is a Serologic Biomarker and a Therapeutic Target for Lung and Esophageal Carcinomas. Cancer Research. 67(24). 11601–11611. 107 indexed citations
16.
Taniwaki, Masaya, Atsushi Takano, Nobuhisa Ishikawa, et al.. (2007). Activation of KIF4A as a Prognostic Biomarker and Therapeutic Target for Lung Cancer. Clinical Cancer Research. 13(22). 6624–6631. 125 indexed citations
17.
Yamabuki, Takumi, Atsushi Takano, Satoshi Hayama, et al.. (2007). Dikkopf-1 as a Novel Serologic and Prognostic Biomarker for Lung and Esophageal Carcinomas. Cancer Research. 67(6). 2517–2525. 182 indexed citations
18.
Takahashi, Koji, Chiyuki Furukawa, Atsushi Takano, et al.. (2006). The Neuromedin U-Growth Hormone Secretagogue Receptor 1b/Neurotensin Receptor 1 Oncogenic Signaling Pathway as a Therapeutic Target for Lung Cancer. Cancer Research. 66(19). 9408–9419. 112 indexed citations
19.
Ishikawa, Nobuhisa, Yataro Daigo, Atsushi Takano, et al.. (2005). Increases of Amphiregulin and Transforming Growth Factor-α in Serum as Predictors of Poor Response to Gefitinib among Patients with Advanced Non–Small Cell Lung Cancers. Cancer Research. 65(20). 9176–9184. 162 indexed citations
20.
Mizuno, Kouichi, Toshii Iida, Atsushi Takano, Mineyuki Yokoyama, & Tatsuhito Fujimura. (2003). A New 9-Lipoxygenase cDNA from Developing Rice Seeds. Plant and Cell Physiology. 44(11). 1168–1175. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jamila Laoukili Breakdown of academic impact, for papers by Kenkichi Masutomi Breakdown of academic impact, for papers by Kiera Rycaj Breakdown of academic impact, for papers by Yongwei Sun Breakdown of academic impact, for papers by Christine Jean Breakdown of academic impact, for papers by Kou‐Juey Wu Breakdown of academic impact, for papers by Assunta De Rienzo Breakdown of academic impact, for papers by Geoffrey Bartholomeusz Breakdown of academic impact, for papers by Wen Cheng Breakdown of academic impact, for papers by Juan Martín‐Caballero
Rankless by CCL
2026